FDA Approval: Tarlatamab
Podcast | English | 2024 | 31 Min
Image For Activity Cover
No Credit Offered

In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recently approved bispecific T-cell engager, tarlatamab, for small cell lung cancer.

Podcast Hosts:
  • Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA 

Podcast Guests: 

  • Anne-Marie Dingemans, MD, PhD, Pulmonologist in the Department of Pulmonary Diseases and Professor of Thoracic Oncology, Erasmus Medical Center, Rotterdam, Netherlands
  • Ryan Gentzler, MD, Associate Professor and Director of the Thoracic Oncology Clinical Research Program, University of Virginia, Charlottesville, VA, USA
Powered By